{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:31:29Z","timestamp":1770823889574,"version":"3.50.1"},"reference-count":166,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1054\/blre.2001.0158","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T14:55:24Z","timestamp":1032447324000},"page":"121-131","source":"Crossref","is-referenced-by-count":66,"title":["Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management"],"prefix":"10.1054","volume":"15","author":[{"given":"A.","family":"Tefferi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1054\/blre.2001.0158_RF1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-2796.1999.00452.x","article-title":"Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count","volume":"245","author":"Griesshammer","year":"1999","journal-title":"J Intern Med"},{"key":"10.1054\/blre.2001.0158_RF2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0037-1963(01)90133-7","article-title":"Chronic myeloid disorders: classification and treatment overview","volume":"38","author":"Tefferi","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0158_RF3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/sj.leu.2400934","article-title":"Clonal development of myeloproliferative disorders: clues to hematopoietic differentiation and multistep pathogenesis of cancer","volume":"12","author":"Raskind","year":"1998","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0158_RF4","first-page":"9","article-title":"Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia","volume":"36","author":"Murphy","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0158_RF5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood.V93.2.415","article-title":"Essential thrombocythemia: another \u2018heterogeneous disease\u2019 better understood?","volume":"93","author":"Nimer","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood.V93.2.417","article-title":"A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications","volume":"93","author":"Harrison","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2141.1999.01667.x","article-title":"Platelet c-mpl expression is dysregulated in patients with essential thrombocythaemia but this is not of diagnostic value","volume":"107","author":"Harrison","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1034\/j.1600-0609.2000.90235.x","article-title":"Megakaryocyte c-Mpl expression in chronic myeloproliferative disorders and the myelodysplastic syndrome: immunoperoxidase staining patterns and clinical correlates","volume":"65","author":"Yoon","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V58.5.916.916","article-title":"Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell","volume":"58","author":"Fialkow","year":"1981","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2141.1995.tb03391.x","article-title":"Clonal analysis of haemopoietic cells in essential thrombocythaemia","volume":"90","author":"el Kassar","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1182\/blood.V89.1.128","article-title":"Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets","volume":"89","author":"elKassar","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF12","first-page":"361","article-title":"Evaluation of clonality in myeloid stem-cell disorders","volume":"36","author":"Gale","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0158_RF13","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1073\/pnas.88.15.6848","article-title":"Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction","volume":"88","author":"Gilliland","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/blre.2001.0158_RF14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0950-3536(98)80039-5","article-title":"Clonality markers in polycythaemia and primary thrombocythaemia","volume":"11","author":"Briere","year":"1998","journal-title":"Baillieres Clin Haematol"},{"key":"10.1054\/blre.2001.0158_RF15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.1365-2141.1997.1933010.x","article-title":"Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes","volume":"97","author":"Champion","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1046\/j.1365-2141.1997.2573078.x","article-title":"Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age","volume":"98","author":"Gale","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0301-472X(00)00649-4","article-title":"Clonality analysis using X-chromosome inactivation patterns by HUMARA-PCR assay in female controls and patients with idiopathic thrombocytosis in Taiwan","volume":"29","author":"Shih","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1054\/blre.2001.0158_RF18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ajcp\/112.1.93","article-title":"Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (HUMARA). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis","volume":"112","author":"Mitterbauer","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.2001.0158_RF19","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1172\/JCI111840","article-title":"Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia","volume":"75","author":"Raskind","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1054\/blre.2001.0158_RF20","first-page":"700a","article-title":"Patients with essential thrombocytemia and clonal hemopoiesis detected by X-inactivation pattern are at high risk for thrombotic complication (abstract)","volume":"94","author":"Chiusolo","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9343(98)00090-4","article-title":"Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis","volume":"104","author":"Wang","year":"1998","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0158_RF22","first-page":"312","article-title":"Patients with thrombocytosis have normal or slightly elevated thrombopoietin levels","volume":"84","author":"Espanol","year":"1999","journal-title":"Haematologica"},{"key":"10.1054\/blre.2001.0158_RF23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1365-2141.1998.00921.x","article-title":"The activating splice mutation in intron 3 of the thrombopoietin gene is not found in patients with non-familial essential thrombocythaemia","volume":"102","author":"Harrison","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF24","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/sj.leu.2400845","article-title":"Study of the thrombopoietin receptor in essential thrombocythemia","volume":"11","author":"Kiladjian","year":"1997","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0158_RF25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood.V92.4.1091","article-title":"Familial essential thrombocythemia associated with one-base deletion in the 5\u2032-untranslated region of the thrombopoietin gene","volume":"92","author":"Kondo","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng0198-49","article-title":"An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia","volume":"18","author":"Wiestner","year":"1998","journal-title":"Nat Genet"},{"key":"10.1054\/blre.2001.0158_RF27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1365-2141.1999.01710.x","article-title":"Hereditary thrombocythaemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene","volume":"107","author":"Ghilardi","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2141.1994.tb08300.x","article-title":"Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF","volume":"87","author":"Li","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1182\/blood.V93.1.125","article-title":"Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L","volume":"93","author":"Taksin","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2141.1993.tb04688.x","article-title":"Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3","volume":"83","author":"Kobayashi","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF31","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1182\/blood.V96.10.3310","article-title":"Hypersensitivity of circulating progenitor cells to megakaryocyte growth and development factor (PEG-rHu MGDF) in essential thrombocythemia","volume":"96","author":"Axelrad","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF32","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/blood.V90.10.4031","article-title":"Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia","volume":"90","author":"Horikawa","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V87.2.567.bloodjournal872567","article-title":"Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets","volume":"87","author":"Stoffel","year":"1996","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF34","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1182\/blood.V89.8.2782","article-title":"Human platelets as a model for the binding and degradation of thrombopoietin","volume":"89","author":"Fielder","year":"1997","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2141.1999.01571.x","article-title":"Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics","volume":"106","author":"Li","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF36","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood.V94.6.1961","volume":"94","author":"Sakamaki","year":"1999","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1182\/blood.V92.1.46.413k44_46_52","article-title":"Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells","volume":"92","author":"Hirayama","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF38","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1038\/sj.leu.2400846","article-title":"Blood thrombopoietin, IL-6 and IL-11 levels in patients with agnogenic myeloid metaplasia","volume":"11","author":"Wang","year":"1997","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0158_RF39","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2141.1998.01054.x","article-title":"Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromes","volume":"103","author":"Tamura","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0158_RF41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1182\/blood.V96.2.771","article-title":"Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis","volume":"96","author":"Tefferi","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2141.2000.01794.x","article-title":"Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera","volume":"108","author":"Le Blanc","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-2141.1998.00529.x","article-title":"Should a platelet limit of 600\u00d7109\/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages","volume":"100","author":"Lengfelder","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF44","first-page":"492","article-title":"Diagnosis of essential thrombocythemia at platelet counts between 400 and 600\u00d7109\/L. Gruppo Italiano Malattie Mieloproliferative Croniche (GIMMC)","volume":"85","author":"Sacchi","year":"2000","journal-title":"Haematologica"},{"key":"10.1054\/blre.2001.0158_RF45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0002-9343(94)90150-3","article-title":"Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases","volume":"96","author":"Buss","year":"1994","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0158_RF46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0140-6736(80)90373-6","article-title":"Platelet millionaires","volume":"2","author":"Schilling","year":"1980","journal-title":"Lancet"},{"key":"10.1054\/blre.2001.0158_RF47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archsurg.1978.01370160087014","article-title":"Deep venous thrombosis and postsplenectomy thrombocytosis","volume":"113","author":"Coon","year":"1978","journal-title":"Arch Surg"},{"key":"10.1054\/blre.2001.0158_RF48","first-page":"309","article-title":"Thrombocytosis in children at one medical center of southern Taiwan","volume":"40","author":"Chen","year":"1999","journal-title":"Acta Paediatr TaiwanS"},{"key":"10.1054\/blre.2001.0158_RF49","first-page":"S95","article-title":"Etiology and incidence of thrombotic and hemorrhagic disorders in Thai patients with extreme thrombocytosis","volume":"83","author":"Chuncharunee","year":"2000","journal-title":"J Med Assoc Thai"},{"key":"10.1054\/blre.2001.0158_RF50","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ajcp\/76.5.685","article-title":"Diagnosis of myeloproliferative disease by analysis of the platelet volume distribution","volume":"76","author":"Small","year":"1981","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.2001.0158_RF51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/ajcp\/90.4.431","article-title":"Platelet parameters and aggregation in essential and reactive thrombocytosis","volume":"90","author":"Sehayek","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.2001.0158_RF52","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/clinchem\/43.6.1072","article-title":"Platelet distribution width for differential diagnosis of thrombocytosis","volume":"43","author":"Osselaer","year":"1997","journal-title":"Clin Chem"},{"key":"10.1054\/blre.2001.0158_RF53","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archinte.1978.03630330051014","article-title":"Template bleeding time and clinical hemorrhage in myeloproliferative disease","volume":"138","author":"Murphy","year":"1978","journal-title":"Arch Intern MedS"},{"key":"10.1054\/blre.2001.0158_RF54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0609.1981.tb01391.x","article-title":"Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests","volume":"25","author":"Boneu","year":"1980","journal-title":"Scand J Haematol"},{"key":"10.1054\/blre.2001.0158_RF55","first-page":"432","article-title":"Abnormal platelet function in myeloproliferative disorders","volume":"105","author":"Waddell","year":"1981","journal-title":"Arch Pathol Lab Med"},{"key":"10.1054\/blre.2001.0158_RF56","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1600-0609.1989.tb00332.x","article-title":"Qualitative platelet defects in chronic myeloproliferative disorders: evidence for reduced ATP secretion","volume":"43","author":"Lofvenberg","year":"1989","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF57","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1600-0609.1991.tb01855.x","article-title":"An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications","volume":"47","author":"Zahavi","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/ajcp\/95.1.82","article-title":"Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders","volume":"95","author":"Balduini","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.2001.0158_RF59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s002770000261","article-title":"A bone marrow report of absent stainable iron is not diagnostic of iron deficiency","volume":"80","author":"Barron","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0158_RF60","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.1991.tb04534.x","article-title":"Elevated serum interleukin-6 levels in patients with reactive thrombocytosis","volume":"79","author":"Hollen","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF61","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/0002-9343(94)90306-9","article-title":"Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis","volume":"97","author":"Tefferi","year":"1994","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0158_RF62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2257.1994.tb00400.x","article-title":"Primary thrombocythaemia: a composite approach to diagnosis","volume":"16","author":"Messinezy","year":"1994","journal-title":"Clin Lab Haematol"},{"key":"10.1054\/blre.2001.0158_RF63","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002770050446","article-title":"Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis","volume":"77","author":"Uppenkamp","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0158_RF64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0609.1998.tb01071.x","article-title":"Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocythaemia and reactive thrombocytosis","volume":"61","author":"Hou","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF65","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2141.1997.3823196.x","article-title":"Thrombopoietin levels in patients with primary and reactive thrombocytosis","volume":"99","author":"Cerutti","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF66","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2000.02430.x","article-title":"The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia","volume":"111","author":"Li","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF67","first-page":"742a","article-title":"Clinical correlates of megakaryocyte C-Mpl expression in essential thrombocythaemia: a clinicopathologic study of 169 patients (abstract)","volume":"96","author":"Mesa","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF68","first-page":"475","article-title":"Bone marrow and peripheral blood findings in patients with extreme thrombocytosis. A report of 63 cases","volume":"115","author":"Buss","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1054\/blre.2001.0158_RF69","first-page":"17","article-title":"Prognostic significance of bone marrow biopsy in essential thrombocythemia","volume":"84","author":"Annaloro","year":"1999","journal-title":"Haematologica"},{"key":"10.1054\/blre.2001.0158_RF70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ajh.2830240104","article-title":"Megakaryocytic colony formation (CFU-Meg) in essential thrombocythemia: quantitative and qualitative abnormalties of bone marrow CFU-Meg","volume":"24","author":"Kimura","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF71","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4065\/74.2.159","article-title":"Diagnosing polycythemia vera: a paradigm shift","volume":"74","author":"Tefferi","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1054\/blre.2001.0158_RF72","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1034\/j.1600-0609.2000.065005285.x","article-title":"Normal ranges for packed cell volume and hemoglobin concentration in adults: relevance to \u2018apparent polycythemia.\u2019","volume":"65","author":"Fairbanks","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF73","first-page":"271","article-title":"Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia","volume":"9","author":"Florensa","year":"1995","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0158_RF74","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/152581699319768","article-title":"Endogenous erythroid and megakaryocytic colony formation in serum-free, cytokine-free collagen gels","volume":"8","author":"Dobo","year":"1999","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1054\/blre.2001.0158_RF75","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0609.1998.tb01040.x","article-title":"Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia","volume":"60","author":"Carneskog","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF76","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1182\/blood.V95.8.2569","article-title":"Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera","volume":"95","author":"Temerinac","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajh.2830270202","article-title":"Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome","volume":"27","author":"Stoll","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF78","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-4608(89)90127-1","article-title":"Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study","volume":"43","author":"Sessarego","year":"1989","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1054\/blre.2001.0158_RF79","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/10428199909058492","article-title":"Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome","volume":"34","author":"Gupta","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1054\/blre.2001.0158_RF80","first-page":"517","article-title":"5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders? (letter)","volume":"9","author":"Koike","year":"1995","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0158_RF81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/10428199909058421","article-title":"Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry, and immunostaining from bone marrow biopsies","volume":"33","author":"Thiele","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1054\/blre.2001.0158_RF82","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1182\/blood.V91.9.3357","article-title":"Highly sensitive fluorescence in situ hybridization method to detect double BCR\/ABL fusion and monitor response to therapy in chronic myeloid leukemia","volume":"91","author":"Dewald","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF83","first-page":"95","article-title":"Morphology and classification of the myelodysplastic syndromes and their pathologic variants","volume":"33","author":"Kouides","year":"1996","journal-title":"Semin Hematol"},{"key":"10.1054\/blre.2001.0158_RF84","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0158_RF85","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4065\/76.1.22","article-title":"A long-term retrospective study of young women with essential thrombocythemia","volume":"76","author":"Tefferi","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1054\/blre.2001.0158_RF86","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/1097-0142(19900801)66:3<549::AID-CNCR2820660324>3.0.CO;2-6","article-title":"Clinical course of essential thrombocythemia in 147 cases","volume":"66","author":"Fenaux","year":"1990","journal-title":"Cancer"},{"key":"10.1054\/blre.2001.0158_RF87","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj.leu.2401270","article-title":"Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients","volume":"13","author":"Besses","year":"1999","journal-title":"Leukemia"},{"key":"10.1054\/blre.2001.0158_RF88","doi-asserted-by":"crossref","first-page":"466","DOI":"10.7326\/0003-4819-102-4-466","article-title":"Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia","volume":"102","author":"Michiels","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1054\/blre.2001.0158_RF89","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000204873","article-title":"Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients","volume":"85","author":"Cervantes","year":"1991","journal-title":"Acta Haematol"},{"key":"10.1054\/blre.2001.0158_RF90","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1054\/blre.2001.0158_RF91","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2141.1998.01021.x","article-title":"No treatment for low-risk thrombocythaemia: results from a prospective study","volume":"103","author":"Ruggeri","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF92","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/1097-0142(19910601)67:11<2926::AID-CNCR2820671136>3.0.CO;2-3","article-title":"Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients","volume":"67","author":"Colombi","year":"1991","journal-title":"Cancer"},{"key":"10.1054\/blre.2001.0158_RF93","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2141.1993.tb08272.x","article-title":"Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factors","volume":"83","author":"Watson","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF94","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s002770050555","article-title":"Thrombosis-free survival and life expectancy in 187 consecutive patients with essential thrombocythemia","volume":"78","author":"Bazzan","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0158_RF95","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0268-960X(98)90026-1","article-title":"The use of aspirin in polycythaemia vera and primary thrombocythaemia","volume":"12","author":"Willoughby","year":"1998","journal-title":"Blood Rev"},{"key":"10.1054\/blre.2001.0158_RF96","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1365-2141.1997.d01-2127.x","article-title":"Prevention and treatment of thrombotic complications in essential thrombocythaemia: efficacy and safety of aspirin","volume":"97","author":"van Genderen","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF97","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V64.5.981.981","article-title":"Acquired von Willebrand's disease in the myeloproliferative syndrome","volume":"64","author":"Budde","year":"1984","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF98","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2141.1986.tb07497.x","article-title":"Abnormalities of von Willenbrand factor in myeloproliferative disease: a relationship with bleeding diathesis","volume":"63","author":"Fabris","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF99","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s002770050345","article-title":"Excessive prolongation of the bleeding time by aspirin in essential thrombocythemia is related to a decrease of large von Willebrand factor multimers in plasma","volume":"75","author":"van Genderen","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0158_RF100","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM199504273321704","article-title":"Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis","volume":"332","author":"Cortelazzo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0158_RF101","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V97.4.863","article-title":"Long-term use of anagrelide in young patients with essential thrombocythemia","volume":"97","author":"Storen","year":"2001","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF102","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/(SICI)1096-8652(199711)56:3<168::AID-AJH6>3.0.CO;2-W","article-title":"Thrombotic complications in essential thrombocythemia with relatively low platelet counts","volume":"56","author":"Regev","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF103","first-page":"135","article-title":"Studies of von Willebrand factor in essential thrombocythemia patients treated with alpha-2b recombinant interferon","volume":"21","author":"Mazzucconi","year":"1991","journal-title":"Haemostasis"},{"key":"10.1054\/blre.2001.0158_RF104","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","article-title":"Essential thrombocythemias. Clinical evolutionary and biological data","volume":"58","author":"Bellucci","year":"1986","journal-title":"Cancer"},{"key":"10.1054\/blre.2001.0158_RF105","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJM198805193182002","article-title":"Anagrelide: a new drug for treating thrombocytosis","volume":"318","author":"Silverstein","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1054\/blre.2001.0158_RF106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90017-6","volume":"92","year":"1992","journal-title":"Am J Med"},{"key":"10.1054\/blre.2001.0158_RF107","first-page":"315","article-title":"Therapy with anagrelide in patients affected by essential thrombocythemia: preliminary results","volume":"77","author":"Mazzucconi","year":"1992","journal-title":"Haematologica"},{"key":"10.1054\/blre.2001.0158_RF108","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-3476(95)70090-0","article-title":"Treatment of essential thrombocythemia with anagrelide","volume":"127","author":"Chintagumpala","year":"1995","journal-title":"J Pediatr"},{"key":"10.1054\/blre.2001.0158_RF109","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00043426-199809000-00012","article-title":"Treatment of children with anagrelide for thrombocythemia","volume":"20","author":"Lackner","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1054\/blre.2001.0158_RF110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1445-5994.1999.tb01585.x","article-title":"Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemia","volume":"29","author":"Mills","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.1054\/blre.2001.0158_RF111","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0609.1998.tb01064.x","article-title":"Anagrelide, a novel platelet lowering option in essential thrombocythaemia: treatment experience in 48 patients in Germany","volume":"61","author":"Petrides","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF112","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2007-996112","article-title":"Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of action, efficacy, toxicity, current indications","volume":"23","author":"Tefferi","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0158_RF113","first-page":"306","article-title":"Pipobroman therapy of essential thrombocythemia","volume":"37","author":"Mazzucconi","year":"1986","journal-title":"Scand J Haematol"},{"key":"10.1054\/blre.2001.0158_RF114","first-page":"1339","article-title":"Efficacy trial of pipobroman in essential thrombocythemia: a study of 24 patients","volume":"68","author":"Brusamolino","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"10.1054\/blre.2001.0158_RF115","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood.V91.2.616","article-title":"Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion","volume":"91","author":"Sterkers","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF116","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF01703444","article-title":"Interferon alpha-2b in the long-term treatment of essential thrombocythemia","volume":"63","author":"Sacchi","year":"1991","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0158_RF117","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1055\/s-2007-996123","article-title":"Interferon-alpha therapy in polycythemia vera and essential thrombocythemia","volume":"23","author":"Elliott","year":"1997","journal-title":"Semin Thromb Hemost"},{"key":"10.1054\/blre.2001.0158_RF118","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10428199909145955","article-title":"Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemia","volume":"36","author":"Bentley","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1054\/blre.2001.0158_RF119","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0009-9260(89)80092-3","article-title":"The treatment of essential thrombocythaemia with radioactive phosphorus","volume":"40","author":"Wagner","year":"1989","journal-title":"Clin Radiol"},{"key":"10.1054\/blre.2001.0158_RF120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0609.1995.tb01621.x","article-title":"Survival and risk of leukaemia in polycythaemia vera and essential thrombocythaemia treated with oral radiophosphorus: are safer drugs available?","volume":"54","author":"Brandt","year":"1995","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF121","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1259\/bjr.70.839.9536909","article-title":"Outcome of 259 patients with primary proliferative polycythaemia (PPP) and idiopathic thrombocythaemia (IT) treated in a regional nuclear medicine department with phosphorus-32\u2013a 15 year review","volume":"70","author":"Balan","year":"1997","journal-title":"Br J Radiol"},{"key":"10.1054\/blre.2001.0158_RF122","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2141.1986.tb02926.x","article-title":"Primary thrombocythaemia treated with busulphan","volume":"62","author":"Van de Pette","year":"1986","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF123","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10428190009089438","article-title":"Leukemia and myelodysplasia effect of multiple cytotoxic therapy in essential thrombocythemia","volume":"37","author":"Randi","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1054\/blre.2001.0158_RF124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00282-997-0011-x","article-title":"Is treatment with hydroxyurea leukemogenic in patients with essential thrombocythemia? An analysis of three new cases of leukaemic transformation and review of the literature","volume":"39","author":"Liozon","year":"1997","journal-title":"Hematol Cell Ther"},{"key":"10.1054\/blre.2001.0158_RF125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<137::AID-AJH7>3.0.CO;2-Z","article-title":"Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea","volume":"51","author":"Furgerson","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF126","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-0609.1994.tb01303.x","article-title":"Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications","volume":"52","author":"Weinfeld","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF127","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V95.11.3589","article-title":"Acquired DNA mutations associated with in vivo hydroxyurea exposure","volume":"95","author":"Hanft","year":"2000","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1096-8652(199605)52:1<42::AID-AJH7>3.0.CO;2-6","article-title":"Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"52","author":"Nand","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000204260","article-title":"Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation\u2014a brief review of recent literature","volume":"91","author":"Shibata","year":"1994","journal-title":"Acta Haematol"},{"key":"10.1054\/blre.2001.0158_RF130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ajcp\/77.3.353","article-title":"Acute leukemia as a natural sequel to primary thrombocythemia","volume":"77","author":"Geller","year":"1982","journal-title":"Am J Clin Pathol"},{"key":"10.1054\/blre.2001.0158_RF131","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s002770050007","article-title":"Leukemic transformation of essential thrombocythemia without previous cytoreductive treatment","volume":"79","author":"Andersson","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0158_RF132","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1182\/blood.V92.4.1459","article-title":"Is hydroxyurea leukemogenic in essential thrombocythemia?","volume":"92","author":"Tefferi","year":"1998","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF133","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2141.2000.02188.x","article-title":"Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial","volume":"110","author":"Finazzi","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF134","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1034\/j.1600-0609.2001.00367.x","article-title":"A single institutional experience with 43 pregnancies in essential thrombocythemia","volume":"66","author":"Wright","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF135","first-page":"374","article-title":"Managing miscarriage","volume":"236","author":"Regan","year":"1992","journal-title":"Practitioner"},{"key":"10.1054\/blre.2001.0158_RF136","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ajh.2830250316","article-title":"Essential thrombocythemia associated with recurrent abortions and fetal growth retardation","volume":"25","author":"Falconer","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF137","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/j.1600-0412.1998.771014.x","article-title":"Successful pregnancies after recurrent abortions in mild essential thrombocythemia","volume":"77","author":"Kaaja","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1054\/blre.2001.0158_RF138","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajh.2830330106","article-title":"Clinical manifestations of essential thrombocythemia in young adults","volume":"33","author":"Millard","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF139","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1471-0528.1989.tb03203.x","article-title":"Thrombocythaemia and recurrent miscarriage","volume":"96","author":"Johnson","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1054\/blre.2001.0158_RF140","first-page":"100","article-title":"Different outcomes of pregnancy in women with essential thrombocytosis","volume":"29","author":"Lishner","year":"1993","journal-title":"Isr J Med Sci"},{"key":"10.1054\/blre.2001.0158_RF141","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0308-2261(21)00376-3","article-title":"Thrombocytosis and thrombocythaemia","volume":"12","author":"Murphy","year":"1983","journal-title":"Clin Haematol"},{"key":"10.1054\/blre.2001.0158_RF142","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1536\/ihj.22.439","article-title":"Primary thrombocythemia and myocardial infarction in a 26-year-old woman with normal coronary arteriogram","volume":"22","author":"Okayasu","year":"1981","journal-title":"Jpn Heart J"},{"key":"10.1054\/blre.2001.0158_RF143","first-page":"386","article-title":"Thrombocythaemia and recurrent late abortions: normal outcome of pregnancies after antiaggregatory treatment","volume":"93","author":"Snethlage","year":"1986","journal-title":"Case report. Br J Obstet Gynaecol"},{"key":"10.1054\/blre.2001.0158_RF144","first-page":"185","article-title":"Idiopathic thrombocythemia and pregnancy: a report of a case","volume":"65","author":"Kaibara","year":"1985","journal-title":"Obstet Gynecol"},{"key":"10.1054\/blre.2001.0158_RF145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0002-9378(88)90507-8","article-title":"Primary thrombocythemia in pregnancy: a report of two cases","volume":"159","author":"Mercer","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1054\/blre.2001.0158_RF146","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0028-2243(91)90124-4","article-title":"Idiopathic thrombocythemia and pregnancy; a case report","volume":"40","author":"Minkhorst","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1054\/blre.2001.0158_RF147","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ajh.2830360316","article-title":"Essential thrombocythemia and complications of pregnancy (letter to the editor)","volume":"36","author":"Pineo","year":"1991","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF148","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<6::AID-AJH2>3.0.CO;2-V","article-title":"Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases","volume":"53","author":"Pagliaro","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF149","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2141.1991.tb08586.x","article-title":"Primary thrombocythaemia in pregnancy","volume":"77","author":"Beard","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF150","first-page":"115","article-title":"Pregnancy in a young woman affected by essential thrombocythemia: a case report","volume":"74","author":"Ferrari","year":"1989","journal-title":"Haematologica"},{"key":"10.1054\/blre.2001.0158_RF151","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s002770050461","article-title":"Treatment of essential thrombocythemia during pregnancy: antiabortive effect of interferon-alpha?","volume":"77","author":"Schmidt","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1054\/blre.2001.0158_RF152","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/10428199609074361","article-title":"Essential thrombocythemia and pregnancy","volume":"22","author":"Grieshammer","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1054\/blre.2001.0158_RF153","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00006254-199704000-00021","article-title":"Essential thrombocythemia during pregnancy","volume":"52","author":"Eliyahu","year":"1997","journal-title":"Obstet Gynecol Surv"},{"key":"10.1054\/blre.2001.0158_RF154","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-2141.1996.d01-1476.x","article-title":"Transient normal platelet counts and decreased requirement for interferon during pregnancy in essential thrombocythaemia","volume":"92","author":"Shpilberg","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF155","first-page":"814","article-title":"Treatment of essential thrombocythemia during pregnancy with interferon-alpha","volume":"87","author":"Delage","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1054\/blre.2001.0158_RF156","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajh.2830400122","article-title":"Normal pregnancy in a patient with essential thrombocythemia treated with interferon-alpha 2b","volume":"40","author":"Petit","year":"1992","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF157","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajh.2830430125","article-title":"Alpha 2b-interferon therapy and pregnancy\u2014report of a case of essential thrombocythemia (letter to the editor)","volume":"43","author":"Pardini","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF158","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1600-0609.1994.tb01287.x","article-title":"Successful treatment of essential thrombocythemia with alpha interferon during pregnancy (letter to the editor)","volume":"52","author":"Thornley","year":"1994","journal-title":"Eur J Haematol"},{"key":"10.1054\/blre.2001.0158_RF159","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood.V83.3.874.874","article-title":"Interferon-alpha 2a treatment in a pregnant woman with essential thrombocythemia (letter to the editor)","volume":"83","author":"Vianelli","year":"1994","journal-title":"Blood"},{"key":"10.1054\/blre.2001.0158_RF160","first-page":"74","article-title":"Successful treatment of essential thrombocythemia in a pregnancy with recombinant interferon-alpha 2a","volume":"5","author":"Milano","year":"1996","journal-title":"J Matern Fetal Med"},{"key":"10.1054\/blre.2001.0158_RF161","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2141.1994.tb05092.x","article-title":"Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon","volume":"88","author":"Williams","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF162","first-page":"495","article-title":"Platelet counts during pregnancy in essential thrombocythaemia treated with recombinant alpha-interferon (letter)","volume":"93","author":"Pulik","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1054\/blre.2001.0158_RF163","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1096-8652(199608)52:4<331::AID-AJH21>3.0.CO;2-F","article-title":"Childbearing age patients with essential thrombocythemia: should they be placed on interferon?","volume":"52","author":"Diez-Martin","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF164","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0163-7258(97)82004-9","article-title":"Cytotoxic therapy and pregnancy","volume":"74","author":"Ebert","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1054\/blre.2001.0158_RF165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/(SICI)1096-8652(199902)60:2<148::AID-AJH12>3.0.CO;2-I","article-title":"Hydroxyurea use during pregnancy: a case report in sickle cell disease and review of the literature","volume":"60","author":"Diav-Citrin","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1054\/blre.2001.0158_RF166","first-page":"743a","article-title":"Clinical relevance of increased angiogenesis in essential thrombocythemia: a clinicopathologic study of 164 patients (abstract)","volume":"96","author":"Mesa","year":"2000","journal-title":"Blood"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X01901584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T22:28:35Z","timestamp":1704320915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X01901584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":166,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["S0268960X01901584"],"URL":"https:\/\/doi.org\/10.1054\/blre.2001.0158","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}